|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Biomimetic Therapeutics, Inc. (BMTI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
19 |
|
|
|
Total
Direct Shares :
|
876,611 |
|
|
Total
Indirect Shares :
|
4,725,404 |
| |
%
Held by Insiders:
|
3.13% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Papasan Larry W |
Director |
2013-03-01 |
0 |
|
0 |
| Pagano Russell P. |
VP, Reg. & Clinical Affairs |
2013-03-01 |
0 |
2010-10-18 |
0 |
| Friedlaender Gary E |
Director |
2013-03-01 |
0 |
2013-03-01 |
0 |
| Federico Charles |
Director |
2013-03-01 |
0 |
2008-03-28 |
0 |
| Lynch Samuel Eugene |
President and CEO, Director |
2013-03-01 |
0 |
2013-03-01 |
0 |
| Bullock Lawrence E |
Chief Financial Officer |
2013-03-01 |
0 |
2013-03-01 |
0 |
| Murphy James G |
Director |
2013-03-01 |
0 |
2008-03-28 |
0 |
| Novo A/s |
10% Owner |
2013-03-01 |
0 |
2006-05-11 |
0 |
| Christensen Thorkil K. |
Director |
2013-03-01 |
0 |
|
0 |
| Watson Douglas G |
Director |
2013-03-01 |
0 |
|
0 |
| Ehrlich Christopher B |
Director |
2013-03-01 |
0 |
2013-03-01 |
0 |
| Douglas Earl Martin |
General Counsel |
2012-03-28 |
11,056 |
2008-01-23 |
0 |
| Hirsch Steven Neal |
COO & Executive VP |
2010-03-23 |
182,491 |
2010-03-23 |
0 |
| Hart Charles Edward |
Chief Scientific Officer &VP |
2008-08-04 |
72,499 |
2008-03-31 |
0 |
| Monsor James A. |
VP - Operations |
2008-03-05 |
56,875 |
2008-03-05 |
200 |
| Citron Mark Barry |
Former Officer |
2007-06-04 |
109,152 |
2007-06-04 |
0 |
| Burrill & Co (biotechnology Gp), Llc |
10% Owner |
2006-11-23 |
444,538 |
2006-05-11 |
0 |
| Dyrberg Thomas |
Director, 10% Owner |
|
0 |
2007-01-25 |
2,371,771 |
| Hanham Ann |
Director, 10% Owner |
|
0 |
2006-05-11 |
2,353,433 |
|
|
